R-CHOP Benefits Older Mantle-Cell Lymphoma Patients Journal of the American Academy of Physician Assistants (HealthDay News) – In older patients with mantle-cell lymphoma, a rituximab-based chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [R-CHOP]) followed by maintenance therapy with rituximab improves survival, ... |
